CClinicalTrials.gg
CompletedNCT06486532Updated May 11, 2025

HeartBeet Clinic Pilot Trial

An interventional study of HeartBeet Clinic and Self-paced education in Hyperlipidemia and Hypertension, sponsored by HealthPartners Institute. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-05-11.

Sponsored by HealthPartners Institute · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The goal of the current study is to conduct a pilot randomized controlled trial comparing the HeartBeet Clinic, a 16-week lifestyle medicine program with virtual, small-group coaching, to a self-paced, online education program. In this pilot study, the primary goals will be to assess acceptability and feasibility of the study and intervention procedures to prepare for a larger efficacy trial.

Read the detailed description

Individuals randomized to the 16-week HeartBeet Clinic lifestyle medicine intervention will complete two in-person group visits, one at the beginning and one at the end of the program. They will also attend group coaching sessions that will be held virtually, using an online coaching platform that will house the self-paced course, intervention materials, and schedule for the coaching and live events. Individuals in this group will be asked to attend 12 group coaching sessions with a health coach, 6 skills sessions to enhance behavior change skills with a health coach, and 6 deep dives with subject matter experts. These sessions will require 1-2 hours of participation per week. In addition, participants will be asked to work through the self-paced course and workbook activities on their own between sessions.

Individuals randomized to the self-paced education group will have access to the virtual coaching platform for the self-paced course and workbook. They will receive email reminders to work through the workbook activities. They will not have contact with the study clinician or health coach except to troubleshoot technical issues.

02

Conditions studied

  • Hyperlipidemia
  • Hypertension

Browse trials for

Keywords

  • Cardiovascular health
03

In context

Hyperlipidemias

821 studies on the registry are indexed under Hyperlipidemias; 105 are open to participants now.

This study's enrollment of 60 is below the median of 87 across 691 interventional studies indexed under Hyperlipidemias.

Browse Hyperlipidemias studies →

Lead sponsor

HealthPartners Institute is the lead sponsor of 164 studies on the registry; 20 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 16 (94%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Have at least one cardiovascular risk factor, including: a) high cholesterol, as defined as diagnosis of hyperlipidemia and/or most recent total cholesterol > 200 or b) hypertension (as defined by a diagnosis of hypertension and/or active antihypertensive medication prescription) and/or BMI > 27
  • Identify as a HealthPartners patient, including having an outpatient encounter with a HealthPartners or Park Nicollet clinician in the prior year
  • Be willing to pay for copays/charges for group medical visit and labs drawn as part of usual care if not fully covered by insurance
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Willingness to maintain current doses of statin, anti-obesity medication, and/or antihypertensive medication during the study
  • Willingness and ability to attend weekly group coaching sessions for 16 weeks at ≥ 1 scheduled group coaching time
  • Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access

Exclusion criteria

Exclusion Criteria:

  • Concurrent participation in another treatment or intervention study
  • History of coronary artery, cerebrovascular or peripheral arterial disease including myocardial infarction, unstable angina, revascularization, stroke/TIA, carotid intervention, claudication, or congestive heart failure
  • Existing diagnosis of dementia and/or other cognitive impairment that would be a barrier to participation
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    HeartBeet Clinic

    16 week group based lifestyle intervention

    Behavioral: HeartBeet Clinic

  • Active comparator
    Self-paced education

    Online learning of lifestyle medicine

    Behavioral: Self-paced education

Interventions

  • BehavioralHeartBeet Clinic

    16 weeks of group based lifestyle medicine coaching covering the six pillars of lifestyle medicine. The six pillars of lifestyle medicine include regular physical activity; a whole-food plant-based diet; restorative sleep; limiting substance use (e.g., tobacco and alcohol use); having meaningful social connections; and stress management. Groups will be led by clinician or health coach expert.

  • BehavioralSelf-paced education

    Self-paced course and workbook with no contact with study clinician or health coach expert

06

What researchers measure

Primary outcomes

  1. Acceptability

    Assess the acceptability using Client Satisfaction Questionnaire (CSQ-8; Larsen et al., 1979). Participants report the extent to which the intervention met their expectations on a 8-item scale. Participants rate the quality of the service and their satisfaction with the services provided on a 4-point Likert-type scale with varying response options (e.g., "How would you rate the quality of the service you received? 4 = Excellent, 3 = Good, 2 = Fair, or 1 = Poor). Items were summed for a total score ranging from 8 to 32, with higher scores corresponding to greater satisfaction with treatment.

    Time frame: Within 2 weeks post-intervention

Secondary outcomes

  1. Recruitment and Retention feasibility

    Assess feasibility of the intervention based on meeting recruitment and retention targets.

    Time frame: End of study (5 months)

  2. Cardiovascular health

    Cardiovascular health will be measured by Life's Essential 8 (Lloyd-Jones et al., 2022), a composite measure that includes 8 domains: diet quality, physical activity, smoking, sleep, lipids, blood pressure, blood glucose, and body mass index. Each domain is scored on a scale from 0-100; a total cardiovascular health score is the average of the 8 domains.

    Time frame: Within 2 weeks post-intervention

07

Study locations

1 site
  • Park Nicollet Cardiology
    Saint Louis Park, Minnesota 55426, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06486532
Lead sponsor
HealthPartners Institute
Responsible party
Stephanie Hooker (Research Investigator, HealthPartners Institute) — Principal investigator
First posted
Jul 3, 2024
Start date
Jan 6, 2025
Primary completion
Apr 18, 2025
Completion
May 2, 2025
Last update
May 11, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion